Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection

Background Despite successful ART in people living with HIV infection (PLHIV) they experience increased morbidity and mortality compared with HIV-negative controls. A dominant paradigm is that gut-associated lymphatic tissue (GALT) destruction at the time of primary HIV infection leads to loss of gut integrity, pathological microbial translocation across the compromised gastrointestinal barrier and, consequently, systemic inflammation. We aimed to identify and measure specific changes in the gastrointestinal barrier that might allow bacterial translocation, and their persistence despite initiation of antiretroviral therapy (ART). Method We conducted a cross-sectional study of the gastrointestinal (GIT) barrier in PLHIV and HIV-uninfected controls (HUC). The GIT barrier was assessed as follows: in vivo mucosal imaging using confocal endomicroscopy (CEM); the immunophenotype of GIT and circulating lymphocytes; the gut microbiome; and plasma inflammation markers Tumour Necrosis Factor-α (TNF-α) and Interleukin-6 (IL-6); and the microbial translocation marker sCD14. Results A cohort of PLHIV who initiated ART early, during primary HIV infection (PHI), n=5), and late (chronic HIV infection (CHI), n=7) infection were evaluated for the differential effects of the stage of ART initiation on the GIT barrier compared with HUC (n=6). We observed a significant decrease in the CD4 T-cell count of CHI patients in the left colon (p=0.03) and a trend to a decrease in the terminal ileum (p=0.13). We did not find evidence of increased epithelial permeability by CEM. No significant differences were found in microbial translocation or inflammatory markers in plasma. In gut biopsies, CD8 T-cells, including resident intraepithelial CD103+ cells, did not show any significant elevation of activation in PLHIV, compared to HUC. The majority of residual circulating activated CD38+HLA-DR+ CD8 T-cells did not exhibit gut-homing integrins α4ß7, suggesting that they did not originate in GALT. A significant reduction in the evenness of species distribution in the microbiome of CHI subjects (p=0.016) was observed, with significantly higher relative abundance of the genus Spirochaeta in PHI subjects (p=0.042). Conclusion These data suggest that substantial, non-specific increases in epithelial permeability may not be the most important mechanism of HIV-associated immune activation in well-controlled HIV-positive patients on antiretroviral therapy. Changes in gut microbiota warrant further study.

[1]  M. Horberg,et al.  Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016 , 2020, JAMA network open.

[2]  T. Lesker,et al.  Perturbation of the gut microbiome by Prevotella spp. enhances host susceptibility to mucosal inflammation , 2020, Mucosal Immunology.

[3]  M. Goetz,et al.  Local barrier dysfunction identified by confocal laser endomicroscopy predicts bacterial translocation in HIV infection. , 2020, AIDS.

[4]  S. Lewin,et al.  Human Immunodeficiency Virus (HIV)–Infected CCR6+ Rectal CD4+ T Cells and HIV Persistence On Antiretroviral Therapy , 2019, The Journal of infectious diseases.

[5]  J. Mellors,et al.  Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance. , 2019, The Journal of clinical investigation.

[6]  D. Cooper,et al.  Quantification of Residual Germinal Center Activity and HIV-1 DNA and RNA Levels Using Fine Needle Biopsies of Lymph Nodes During Antiretroviral Therapy. , 2017, AIDS research and human retroviruses.

[7]  S. Kent,et al.  Divergent Expression of CXCR5 and CCR5 on CD4+ T Cells and the Paradoxical Accumulation of T Follicular Helper Cells during HIV Infection , 2017, Front. Immunol..

[8]  Daniel Frank,et al.  Inside Out: HIV, the Gut Microbiome, and the Mucosal Immune System , 2017, The Journal of Immunology.

[9]  D. Cooper,et al.  CD4+ T Follicular Helper and IgA+ B Cell Numbers in Gut Biopsies from HIV-Infected Subjects on Antiretroviral Therapy Are Similar to HIV-Uninfected Individuals , 2016, Front. Immunol..

[10]  Frédéric Leroy,et al.  Bifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human Gut , 2016, Front. Microbiol..

[11]  G. Pantaleo,et al.  PD-1+ and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals , 2016, Nature Medicine.

[12]  A. d’Arminio Monforte,et al.  Impaired gut junctional complexes feature late-treated individuals with suboptimal CD4+ T-cell recovery upon virologically suppressive combination antiretroviral therapy , 2016, AIDS.

[13]  Tri Giang Phan,et al.  The learning curve, interobserver, and intraobserver agreement of endoscopic confocal laser endomicroscopy in the assessment of mucosal barrier defects. , 2016, Gastrointestinal endoscopy.

[14]  J. Reynes,et al.  Immune activation in the course of HIV‐1 infection: Causes, phenotypes and persistence under therapy , 2016, HIV medicine.

[15]  C. Kahler,et al.  Elevated Soluble CD14 and Lower D-Dimer Are Associated With Cigarette Smoking and Heavy Episodic Alcohol Use in Persons Living With HIV , 2015, Journal of acquired immune deficiency syndromes.

[16]  J. Hofmann,et al.  The effect of timing of antiretroviral therapy on CD4+ T-cell reconstitution in the intestine of HIV-infected patients , 2015, Mucosal Immunology.

[17]  V. Natarajan,et al.  Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels , 2015, AIDS.

[18]  P. Morris,et al.  Deriving accurate microbiota profiles from human samples with low bacterial content through post-sequencing processing of Illumina MiSeq data , 2015, Microbiome.

[19]  P. Viciana,et al.  Differential Effects of Viremia and Microbial Translocation on Immune Activation in HIV-Infected Patients Throughout Ritonavir-Boosted Darunavir Monotherapy , 2015, Medicine.

[20]  C. Tremblay,et al.  Impaired Th17 polarization of phenotypically naive CD4+ T-cells during chronic HIV-1 infection and potential restoration with early ART , 2015, Retrovirology.

[21]  D. Havlir,et al.  Site-Specific Differences in T Cell Frequencies and Phenotypes in the Blood and Gut of HIV-Uninfected and ART-Treated HIV+ Adults , 2015, PloS one.

[22]  A. Caliendo,et al.  Healthy HIV-1-infected individuals on highly active antiretroviral therapy harbor HIV-1 in their alveolar macrophages. , 2015, AIDS research and human retroviruses.

[23]  Jeffrey N. Martin,et al.  Gut epithelial barrier and systemic inflammation during chronic HIV infection , 2015, AIDS.

[24]  M. Wallace,et al.  In‐vivo microscopy in the diagnosis of intestinal neoplasia and inflammatory conditions , 2015, Histopathology.

[25]  J. Schenkel,et al.  Tissue-resident memory T cells. , 2014, Immunity.

[26]  E. N. Cavallari,et al.  Reconstitution of Intestinal CD4 and Th17 T Cells in Antiretroviral Therapy Suppressed HIV-Infected Subjects: Implication for Residual Immune Activation from the Results of a Clinical Trial , 2014, PloS one.

[27]  Ning Li,et al.  γδ T Cells Are Involved in Acute HIV Infection and Associated with AIDS Progression , 2014, PloS one.

[28]  A. Justice,et al.  Aging and HIV: an evolving understanding. , 2014, Current opinion in HIV and AIDS.

[29]  A. Levine,et al.  Progressive Proximal-to-Distal Reduction in Expression of the Tight Junction Complex in Colonic Epithelium of Virally-Suppressed HIV+ Individuals , 2014, PLoS pathogens.

[30]  K. Arheart,et al.  Tobacco Smoking Increases Immune Activation and Impairs T-Cell Function in HIV Infected Patients on Antiretrovirals: A Cross-Sectional Pilot Study , 2014, PloS one.

[31]  R. Kiesslich,et al.  Confocal Endomicroscopy Identifies Loss of Local Barrier Function in the Duodenum of Patients with Crohn's Disease and Ulcerative Colitis , 2014, Inflammatory bowel diseases.

[32]  A. Keshavarzian,et al.  A Compositional Look at the Human Gastrointestinal Microbiome and Immune Activation Parameters in HIV Infected Subjects , 2014, PLoS pathogens.

[33]  S. Gianella,et al.  An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia , 2014, Mucosal Immunology.

[34]  C. Sabin.  Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy? , 2013, BMC Medicine.

[35]  D. Cooper,et al.  The majority of HIV type 1 DNA in circulating CD4+ T lymphocytes is present in non-gut-homing resting memory CD4+ T cells. , 2013, AIDS research and human retroviruses.

[36]  R. Kaul,et al.  Mucosal Th17 Cell Function Is Altered during HIV Infection and Is an Independent Predictor of Systemic Immune Activation , 2013, The Journal of Immunology.

[37]  Ryan D. Hernandez,et al.  Dysbiosis of the Gut Microbiota Is Associated with HIV Disease Progression and Tryptophan Catabolism , 2013, Science Translational Medicine.

[38]  B. Claggett,et al.  Breaks in the wall: increased gaps in the intestinal epithelium of irritable bowel syndrome patients identified by confocal laser endomicroscopy (with videos). , 2013, Gastrointestinal endoscopy.

[39]  J. García,et al.  Impact of highly active antiretroviral therapy initiation on CD4+ T-cell repopulation in duodenal and rectal mucosa , 2013, AIDS.

[40]  J. García,et al.  Short communication: HIV+ viremic slow progressors maintain low regulatory T cell numbers in rectal mucosa but exhibit high T cell activation. , 2013, AIDS research and human retroviruses.

[41]  M. Neurath,et al.  Assessment of Crohn's disease activity by confocal laser endomicroscopy , 2012, Journal of Digestive Endoscopy.

[42]  Nicolae Miron,et al.  Enterocytes: active cells in tolerance to food and microbial antigens in the gut , 2012, Clinical and experimental immunology.

[43]  R. Kiesslich,et al.  Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease , 2011, Gut.

[44]  V. Natarajan,et al.  Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir , 2011, AIDS.

[45]  R. Kaul,et al.  Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation in men on long-term antiretroviral therapy , 2011, AIDS.

[46]  G. Ginsberg,et al.  Disruption of Intestinal CD4+ T Cell Homeostasis Is a Key Marker of Systemic CD4+ T Cell Activation in HIV-Infected Individuals , 2010, The Journal of Immunology.

[47]  C. B. Hare,et al.  Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy , 2010, AIDS.

[48]  G. Stewart,et al.  Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation. , 2010, The Journal of infectious diseases.

[49]  C. Loddenkemper,et al.  Acute HIV infection induces mucosal infiltration with CD4+ and CD8+ T cells, epithelial apoptosis, and a mucosal barrier defect. , 2010, Gastroenterology.

[50]  S. Pittaluga,et al.  Damaged Intestinal Epithelial Integrity Linked to Microbial Translocation in Pathogenic Simian Immunodeficiency Virus Infections , 2010, PLoS pathogens.

[51]  Xiu-Li Zuo,et al.  Classification of Inflammation Activity in Ulcerative Colitis by Confocal Laser Endomicroscopy , 2010, The American Journal of Gastroenterology.

[52]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[53]  T. Hope,et al.  Exposure to HIV-1 Directly Impairs Mucosal Epithelial Barrier Integrity Allowing Microbial Translocation , 2010, PLoS pathogens.

[54]  Richard D Moore,et al.  Kupffer cells are depleted with HIV immunodeficiency and partially recovered with antiretroviral immune reconstitution , 2009, AIDS.

[55]  Ian R. Holzman,et al.  Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. , 2009, The Journal of nutrition.

[56]  C. Loddenkemper,et al.  Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients , 2008, Gut.

[57]  M. Clerici,et al.  Early Impairment of Gut Function and Gut Flora Supporting a Role for Alteration of Gastrointestinal Mucosa in Human Immunodeficiency Virus Pathogenesis , 2007, Journal of Clinical Microbiology.

[58]  T. Ma,et al.  IL-1β Causes an Increase in Intestinal Epithelial Tight Junction Permeability1 , 2007, The Journal of Immunology.

[59]  M. Markowitz,et al.  Lack of Mucosal Immune Reconstitution during Prolonged Treatment of Acute and Early HIV-1 Infection , 2006, PLoS medicine.

[60]  M. Lederman,et al.  Microbial translocation is a cause of systemic immune activation in chronic HIV infection , 2006, Nature Medicine.

[61]  Michael D. George,et al.  Viral Suppression and Immune Restoration in the Gastrointestinal Mucosa of Human Immunodeficiency Virus Type 1-Infected Patients Initiating Therapy during Primary or Chronic Infection , 2006, Journal of Virology.

[62]  D. Price,et al.  CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract , 2004, The Journal of experimental medicine.

[63]  Christine Hogan,et al.  Primary HIV-1 Infection Is Associated with Preferential Depletion of CD4+ T Lymphocytes from Effector Sites in the Gastrointestinal Tract , 2004, The Journal of experimental medicine.

[64]  A. Pedram,et al.  TNF-α-induced increase in intestinal epithelial tight junction permeability requires NF-κB activation , 2004 .

[65]  J. Flamm,et al.  Severe CD4+ T-Cell Depletion in Gut Lymphoid Tissue during Primary Human Immunodeficiency Virus Type 1 Infection and Substantial Delay in Restoration following Highly Active Antiretroviral Therapy , 2003, Journal of Virology.

[66]  A. Mowat,et al.  Anatomical basis of tolerance and immunity to intestinal antigens , 2003, Nature Reviews Immunology.

[67]  A. West,et al.  Distribution of Peyer's Patches in the Distal Ileum , 2002, Inflammatory bowel diseases.

[68]  E. Smecuol,et al.  Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs , 2001, Gut.

[69]  D. Cooper,et al.  Increased turnover of CCR5+ and redistribution of CCR5- CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection. , 2001, The Journal of infectious diseases.

[70]  E. Jirillo,et al.  Invited review: Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance , 2000, Journal of endotoxin research.

[71]  D. Cooper,et al.  Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia. , 1999, The Journal of infectious diseases.

[72]  R. Detels,et al.  Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. , 1993, Journal of acquired immune deficiency syndromes.

[73]  J. Schmitz,et al.  Human Kupffer cells infected with HIV-1 in vivo. , 1993, Journal of acquired immune deficiency syndromes.

[74]  A. Fauci,et al.  Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. , 1983, The New England journal of medicine.

[75]  Martin Goetz,et al.  Microscopic imaging in endoscopy: endomicroscopy and endocytoscopy , 2014, Nature Reviews Gastroenterology &Hepatology.

[76]  F Miedema,et al.  T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). , 2000, Blood.

[77]  R. Andreesen,et al.  Secretory repertoire of HIV-infected human monocytes/macrophages. , 1991, Pathobiology : journal of immunopathology, molecular and cellular biology.

[78]  M. Lipkin.  Growth and development of gastrointestinal cells. , 1985, Annual review of physiology.